Fate Therapeutics
FATE
FATE
238 hedge funds and large institutions have $2.45B invested in Fate Therapeutics in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 79 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.73% less ownership
Funds ownership: 113.36% → 112.62% (-0.73%)
9% less capital invested
Capital invested by funds: $2.69B → $2.45B (-$249M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
238
Holding in Top 10
5
Calls
$2.87M
Puts
$1.55M
Top Buyers
| 1 | +$31.7M | |
| 2 | +$12M | |
| 3 | +$11.2M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$7.42M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$5.5M |
Top Sellers
| 1 | -$41.3M | |
| 2 | -$19.9M | |
| 3 | -$15.8M | |
| 4 |
EP
Eversept Partners
New York
|
-$13.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$9.03M |